Ebola Virus Makona Shows Reduced Lethality in an Immune-deficient Mouse Model

Journal of Infectious Diseases

Volumn 214, Issue , 2016, Pages S268-S274

  Smither, Sophie J ^a   Eastaugh, Lin ^a   Ngugi, Sarah ^a   O'Brien, Lyn ^a   Phelps, Amanda ^a   Steward, Jackie ^a   Lever, Mark Stephen ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Aerosol; Animal model; Antibody response; Ebola virus; Ebola virus disease; Filovirus; Growth curve; Makona; Mouse

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; AEROSOL; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EBOLA VIRUS MAKONA; EBOLAVIRUS; FEMALE; FILOVIRUS; GROWTH RATE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MORTALITY RATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL CLEARANCE; VIROGENESIS; VIRUS INFECTION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BLOOD; DISEASE MODEL; EBOLA HEMORRHAGIC FEVER; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; PATHOGENICITY; PATHOLOGY; VIROLOGY;

AEROSOLS; ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOGLOBULIN G; MICE;

EID: 84990990470     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw145     Document Type: Article

References (43)

1. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-25.
2. World Health Organization. Ebola situation reports. http://apps.who.int/ebola/ebola-situation-reports. Accessed January 2016.
3. Kuhn JH, Andersen KG, Baize S, et al. Nomenclature-and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 2014; 6:4760-99.
4. Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014; 345:1369-72.
5. Carroll MW, Matthews DA, Hiscox JA, et al. Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature 2015; 524:97-101.
6. Kugelman JR, Wiley MR, Mate S, et al. Monitoring of ebola virus makona evolution through establishment of advanced genomic capability in Liberia. Emerg Infect Dis 2015; 21:1135-43.
7. Park DJ, Dudas G,Wohl S, et al. Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone. Cell 2015; 161:1516-26.
8. Cohen J, Enserink M. CLINICAL TRIALS. Ebola vaccines face daunting path to approval. Science 2015; 349:1272-3.
9. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386:857-66.
10. Klenk HD, Becker S. Ebola virus vaccines-preparing for the unexpected. Science 2015; 349:693-4.
11. Friedrich BM, Trefry JC, Biggins JE, et al. Potential vaccines and post-exposure treatments for filovirus infections. Viruses 2012; 4:1619-50.
12. Bradfute SB, Warfield KL, Bray M. Mouse models for filovirus infections. Viruses 2012; 4:1477-508.
13. Nakayama E, Saijo M. Animal models for Ebola and Marburg virus infections. Front Microbiol 2013; 4:267.
14. Smith DR, Holbrook MR, Gowen BB. Animal models of viral hemorrhagic fever. Antiviral Res 2014; 112:59-79.
15. Shurtleff AC, Bavari S. Animal models for ebolavirus countermeasures discovery: what defines a useful model? Expert Opin Drug Discov 2015; 10:685-702.
16. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61.
17. Connolly BM, Steele KE, Davis KJ, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 1999; 179(suppl 1):S203-17.
18. Gibb TR, Bray M, Geisbert TW, et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 2001; 125:233-42.
19. Ebihara H, Zivcec M, Gardner D, et al. A Syrian golden hamster model recapitulating ebola hemorrhagic fever. J Infect Dis 2013; 207:306-18.
20. Wahl-Jensen V, Bollinger L, Safronetz D, de Kok-Mercado F, Scott DP, Ebihara H. Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers. Viruses 2012; 4:3754-84.
21. Bray M. The role of the Type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 2001; 82:1365-73.
22. Warfield KL, Alves DA, Bradfute SB, et al. Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol J 2007; 4:108.
23. Raymond J, Bradfute S, Bray M. Filovirus infection of STAT-1 knockout mice. J Infect Dis 2011; 204(suppl 3):S986-90.
24. Lever MS, Piercy TJ, Steward JA, et al. Lethality and pathogenesis of airborne infection with filoviruses in A129 ?/?-/-interferon receptor-deficient mice. J Med Microbiol 2012; 61:8-15.
25. Brannan JM, Froude JW, Prugar LI, et al. Interferon ?/? receptor-Deficient mice as a model for ebola virus disease. J Infect Dis 2015; 212(suppl 2):S282-94.
26. Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS. Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model. Antiviral Res 2014; 104:153-5.
27. Zumbrun EE, Abdeltawab NF, Bloomfield HA, et al. Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice. Viruses 2012; 4:3468-93.
28. Bird BH, Spengler JR, Chakrabarti AK, et al. Humanized mouse model of Ebola virus disease mimics immune responses in human disease. J Infect Dis 2015; 213:703-11.
29. Rieger T, Merkler D, Günther S. Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers. PLoS One 2013; 8:e72290.
30. Li XF, Deng YQ, Zhao H, et al. Noninvasive bioluminescence imaging of dengue virus infection in the brain of A129 mice. Appl Microbiol Biotechnol 2013; 97:4589-96.
31. Meier KC, Gardner CL, Khoretonenko MV, Klimstra WB, Ryman KD. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog 2009; 5:e1000614.
32. Smither SJ, Lear-Rooney C, Biggins J, Pettitt J, Lever MS, Olinger GG Jr. Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. J Virol Methods 2013; 193:565-71.
33. Kuhn JH, Lofts LL, Kugelman JR, et al. Reidentification of Ebola Virus E718 andME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran. Genome Announc 2014; doi:10.1128/genomeA.01178-14.
34. Guyton AC. Measurement of the respiratory volumes of laboratory animals. Am J Physiol 1947; 150:70-7.
35. Wong G, Richardson JS, Pillet S, et al. Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates. Sci Transl Med 2012; 4:158ra146.
36. Wilson JA, HeveyM, Bakken R, et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000; 287:1664-6.
37. Wauquier N, Becquart P, Gasquet C, Leroy EM. Immunoglobulin G in Ebola outbreak survivors, Gabon. Emerg Infect Dis 2009; 15:1136-7.
38. McElroy AK, Akondy RS, Davis CW, et al. Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A 2015; 112:4719-24.
39. Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 2001; 124:453-60.
40. Rhein BA, Powers LS, Rogers K, et al. Interferon-? inhibits ebola virus infection. PLoS Pathog 2015; 11:e1005263.
41. Smither SJ, Nelson M, Eastaugh L, Nunez A, Salguero FJ, Lever MS. Experimental respiratory infection of marmosets (callithrix jacchus) with Ebola virus kikwit. J Infect Dis 2015; 212(suppl 2):S336-45.
42. Marzi A, Feldmann F, Hanley PW, Scott DP, Günther S, Feldmann H. Delayed disease progression in cynomolgus macaques infected with ebola virus makona strain. Emerg Infect Dis 2015; 21:1777-83.
43. Lefebvre A, Fiet C, Belpois-Duchamp C, Tiv M, Astruc K, Aho Glélé LS. Case fatality rates of Ebola virus diseases: a meta-analysis of World Health Organization data. Med Mal Infect 2014; 44:412-6.